ARWR May 2024 25.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:49PM EDT. Market open.
| Previous close | 0.9400 |
| Open | 1.1000 |
| Bid | 0.1000 |
| Ask | 0.5000 |
| Strike | 25.00 |
| Expiry date | 2024-05-17 |
| Day's range | 0.0500 - 1.1000 |
| Contract range | N/A |
| Volume | |
| Open interest | 566 |
GuruFocus.comArrowhead Pharmaceuticals Reports Substantial Fiscal Q2 Loss, Diverging from Analyst Expectations
Comprehensive Analysis of ARWR's Fiscal 2024 Q2 Earnings Against Market Forecasts
Insider MonkeyArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q2 2024 Earnings Call Transcript
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q2 2024 Earnings Call Transcript May 9, 2024 Arrowhead Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.01634 EPS, expectations were $-0.06. Arrowhead Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and […]
Business WireArrowhead Pharmaceuticals Reports Fiscal 2024 Second Quarter Results
PASADENA, Calif., May 09, 2024--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2024 second quarter ended March 31, 2024. The Company is hosting a conference call today, May 9, 2024, at 4:30 p.m. ET to discuss the results.
© 2024 Yahoo. All rights reserved.